NEW YORK, Sept. 17 – Proteomics company Large Scale Biology Corporation has said it was considering using a recently announced easing of trading restrictions to repurchase up to one million shares of its common stock in the open market.

“The limited share repurchase plan was authorized in connection with the upcoming resumption of trading following this week's lengthy suspension of market activity," LSBC’s CEO Robert Erwin said in a statement released on Friday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.